Objective:

To enhance understanding of patient selection for surgical versus nonsurgical therapies, including specific systemic therapy approaches and local ablative therapies for pancreatic cancer.

Key Findings:

• Survival rates for pancreatic cancer have modestly increased over the last decade.
• Innovative systemic and local treatments, such as MR-guided radiation therapy and irreversible electroporation (IRE), are emerging, improving management and prognosis.
• MRI is more sensitive than CT scans for detecting liver lesions and assessing surgical resectability.

Interpretation:

The advancements in treatment options and imaging techniques are crucial for improving outcomes in pancreatic cancer patients, potentially leading to better survival rates and quality of life.

Limitations:

• The discussion is based on a limited number of cases presented during the symposium, which may not represent the broader patient population.
• The effectiveness of new therapies may vary based on individual patient factors, necessitating further research.

Conclusion:

Ongoing innovations in the management of pancreatic cancer are essential for enhancing patient care and survival rates, highlighting the need for continuous research and development.